Chloroquine Phosphate API Market Analysis and Future Prospects for 2030
Chloroquine Phosphate API Market Analysis and Future Prospects for 2030
Stay updated with breaking news from Ipca Laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Chloroquine Phosphate API Market Analysis and Future Prospects for 2030
The stock rose from Rs 731 on 20 June to Rs 913 recorded on 20 September, which translates into an upside of 24% in 3 months. It hit a fresh 52-week high of Rs 954 on 18 September but witnessed some profit-taking thereafter, largely in line with the trend seen in broader markets
Ipca Labs acquired 33.38 percent of Unichem in August which triggered an open offer. Ipca Labs received the approval of the Competition Commission of India for this acquisition on July 27, 2023
Ipca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 23532.33 Crore) operating in Pharmaceuticals sector.
This means the average traded quantity of the stock for five days along with its cumulative open interest has increased whereas the price has decreased